Nervous Disorder TRIZ Cases

Extending the anti-CD33 antibody dosing interval to 12 weeks reduces patient compliance burden while maintaining therapeutic effectiveness.

5-lipoxygenase inhibitors target dysregulated lipid metabolism to prevent unintended phenotypes and restore motor neuron function in ALS models.

Ethanol-water extraction followed by saponification yields a neuroprotective brain extract that prevents working memory deficits.

Macrocyclic thioester prodrugs activate via hydrolysis to inhibit histone deacetylases, resolving toxicity challenges through Class I selectivity.

Small molecule peptidomimetics disrupt the Cav2.2-CRMP2 interaction to provide analgesic effects without invasive administration or significant side effects.

Sulindac resolves ineffective therapy trade-offs by rescuing social anxiety and memory loss symptoms.

Herpes simplex virus type 1 infected human induced neural stem cells generate Alzheimer's disease phenotypes for high throughput screening.

Nr5a2 replaces Oct4 to boost reprogramming efficiency and reduce time.

A probiotic Bifidobacterium strain modulates cytokine levels to exclude pro-inflammatory microorganisms from the gastrointestinal tract.

Virgin salmon oil encapsulates honokiol and magnolol, reducing degradation below 5.4% over 21 days while improving bioavailability.

Stapled peptides disrupt WASF3 stability by inhibiting CYFIP1 binding, suppressing cancer invasion without affecting cell proliferation.

TRPV4 antagonists block calcium channels to inhibit cerebrospinal fluid production, replacing invasive shunt surgery with a pharmacological approach.

Doxycycline-suppressible expression systems dynamically adjust microRNA-211 concentrations to reduce seizure susceptibility in refractory epilepsy cases.

Combining nicotine with cannabidiol in oral or nasal dosage forms creates a synergistic pharmaceutical composition.

A moisture-permeable membrane triggers active ingredient release from a salt reservoir upon skin contact.

Adeno-associated viral vectors encode anti-tau antibodies in patient cells, eliminating frequent injections and lowering treatment costs.

Multiplexed yeast screening identifies DNAJB6 as a potent rescuer of RNA-binding protein misfolding, preventing aggregation and reducing proteotoxicity.

Modified oligonucleotides with 2′-O-methyl RNA and phosphorothioate backbones overcome the blood-brain barrier to reduce toxic protein levels.

Low-dose recombinant IL-12 stimulates endogenous erythropoietin production, reducing blood transfusion requirements.

Local Botulinum toxin A administration paralyzes facial muscles, reducing PTSD symptoms without systemic side effects of psychotropic agents.

A composition combining long chain polyunsaturated fatty acids, nitric oxide releasing compounds, and medium chain triglycerides enhances cognitive function.

Adenylyl cyclase inhibitors down-regulate AC1 activity, treating neuropathic and inflammatory pain simultaneously without increasing treatment complexity.

N-terminal tetrapeptide extensions modify ShK peptide structure to enhance binding affinity for Kv1.3 ion channels.

N,N-bis-2-mercaptoethyl isophthalamide acts as a heavy metal chelator to inhibit pro-inflammatory markers and modify Aβ42 aggregation.

Segmenting whole plant extracts into controlled THC and CBD ratios resolves the trade-off between therapeutic spectrum and dosage precision.

Protein kinase inhibitors convert fibroblasts directly into oligodendrocyte progenitor cells without viral vectors.

Cytokine fusion proteins combine distinct TNF ligand domains to activate multiple receptor pathways simultaneously.

Cell-free adipose secretions allow remote injection to treat injuries, while pre-added secretions in cryopreservation media maintain stem cell viability.

A selective COX-2 furanone pharmaceutical composition with optimized particle size and excipients.

Cyclic peptides bind amyloid-beta species with high affinity, neutralizing toxic oligomers that conventional treatments fail to prevent.

Antibodies bind citrullinated epitopes on p15 and p17 to prevent joint erosion without broad immunosuppression.

A chimeric polypeptide delivers alpha-amylase into cells to degrade glycogen accumulation.

Complement inhibitors block membrane attack complex formation to facilitate axonal regeneration.

Stereoselective phenoxy propan-2-amine compounds inhibit cardiac sodium channels, reducing CNS side effects and conduction defects associated with Mexiletine.

Generating autologous hematopoietic stem cells from hemogenic endothelial cells via Trpv4 activation or cyclic 2D stretching eliminates donor search time.

Buccal absorption of lavender oil in chewing gum reduces gastrointestinal adverse effects while maintaining therapeutic efficacy.

Targeted residue substitutions in variable domains and Fc regions enhance binding affinity to the BCR complex while reducing immunogenicity.

Antibodies block the sortilin receptor to raise progranulin levels, addressing reduced protein availability in neurodegenerative disorders.

SB623 cell biobridges guide host neurogenic cells to injured brain sites.

Modifying aromatic rings with heteroatoms enhances binding affinity to treat autoimmune diseases and cancers.

Anti-CD8 antibodies deplete cytotoxic T cells, reducing pro-inflammatory gene expression and astrocyte activation to delay ALS progression.

Formula 14-17 compounds target glioblastoma stem cells while simplifying synthesis via deuterium tracking.

Alpha-asarone restores excitatory-inhibitory amino acid balance to prevent secondary epilepsy without damaging neurological function.

Differentiating stem cells into dopaminergic neural precursor cells using optimized signaling inhibitors and activators for mass production.

Agents elevating cAMP restore mitochondrial function and reduce seizure frequency in methylmalonic acidemia.

Deuterium substitution in difluoro phenyl amide prodrugs resolves metabolic stability limitations while maintaining selective RIP1 kinase inhibition.

Amino acid modifications create zymogen-like Factor Xa variants that balance coagulation function with prolonged stability.

Segmented sorption elements manage volatile compound release speed to resolve the trade-off between rapid initial delivery and sustained nicotine duration.

A herbal extract composition increases nerve growth factor levels to promote nerve regeneration.